← Evidence map

ArticleOncogene2017

FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.

H Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

47 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28068319